Sellas Life Sciences Group Inc (SLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -19,292 | -27,670 | -23,754 | -17,681 | -38,956 |
| Depreciation Amortization | N/A | 9,100 | 258 | 3 | 107 |
| Income taxes - deferred | -95 | -1,316 | N/A | -41 | 365 |
| Accounts payable and accrued liabilities | 12 | -7,936 | 8,366 | N/A | -289 |
| Other Working Capital | -1,112 | -10,006 | 6,065 | 1,353 | -4,127 |
| Other Operating Activity | 2,844 | 7,406 | -1,924 | 4,516 | -5,260 |
| Operating Cash Flow | $-17,643 | $-30,422 | $-10,989 | $-11,850 | $-48,160 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | N/A | -153 |
| Net Acquisitions | N/A | N/A | 12,158 | N/A | N/A |
| Other Investing Activity | 0 | 0 | 0 | -85 | 10,548 |
| Investing Cash Flow | $N/A | $N/A | $12,158 | $-85 | $10,395 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | -7,601 | N/A | 16,500 | 0 |
| Debt Repayment | N/A | N/A | -473 | N/A | -3,911 |
| Common Stock Issued | 19,569 | 21,564 | 6,007 | 0 | 47,756 |
| Dividend Paid | N/A | -487 | N/A | N/A | N/A |
| Other Financing Activity | 0 | 9,647 | 0 | 0 | 0 |
| Financing Cash Flow | $19,569 | $23,123 | $5,534 | $16,500 | $43,845 |
| Beginning Cash Position | 5,451 | 12,750 | 6,047 | 1,397 | 23,650 |
| End Cash Position | 7,377 | 5,451 | 12,750 | 5,962 | 29,730 |
| Net Cash Flow | $1,926 | $-7,299 | $6,703 | $4,565 | $6,080 |
| Free Cash Flow | |||||
| Operating Cash Flow | -17,643 | -30,422 | -10,989 | -11,850 | -48,160 |
| Capital Expenditure | N/A | N/A | N/A | N/A | -153 |
| Free Cash Flow | -17,643 | -30,422 | -10,989 | -11,850 | -48,313 |